Heimdall Insights

Global Hyperphosphatemia Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Hyperphosphatemia Market was valued at $3.9 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 7.8% CAGR, to an estimated market size of $5.6 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global hyperphosphatemia market comprises pharmaceutical therapeutics, primarily phosphate binders and intestinal phosphate absorption inhibitors, used to manage elevated serum phosphorus levels. The scope includes treatments for patients with Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD), particularly those undergoing dialysis, while excluding general nutritional supplements and unrelated renal diagnostic equipment.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Hyperphosphatemia Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Non-Calcium Binders (Sevelamer/Lanthanum)
  • Calcium-Based Binders
  • Iron-Based Binders
  • Novel Agents (NHE3 Inhibitors/Others)